KDR is a key player in initiating angiogenesis and a drug target in several cancers, including ovarian carcinoma [73], while VIM is a marker of the epithelial-mesenchymal transition, and there is growing evidence of its involvement in epithelial cancers [74]. Here, KDR is linked to cancer.